Steven I. Park, M.D.

CBES Area of Interest:

My second major area of research is antibody-directed targeted therapy and imaging for NHL. My group has developed a pretargeted approach to effectively target NHL using nanoparticles.

CBES Area of Expertise:

My research is primarily focused on targeted therapy for non-Hodgkin lymphoma (NHL). My group has examined various signaling pathways, including PI3K/mTOR, aurora kinases, and Myc, and their impact on the initiation and progression of lymphoma. We have performed translational research to identify novel anti-lymphoma compounds in preclinical models.